Correlation Between Daihan Pharmaceutical and InnoTherapy

Can any of the company-specific risk be diversified away by investing in both Daihan Pharmaceutical and InnoTherapy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Daihan Pharmaceutical and InnoTherapy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Daihan Pharmaceutical CoLtd and InnoTherapy, you can compare the effects of market volatilities on Daihan Pharmaceutical and InnoTherapy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Daihan Pharmaceutical with a short position of InnoTherapy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Daihan Pharmaceutical and InnoTherapy.

Diversification Opportunities for Daihan Pharmaceutical and InnoTherapy

0.55

Correlation Coefficient

Daihan Pharmaceutical  InnoTherapy

Very weak diversification

The 3 months correlation between Daihan and InnoTherapy is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Daihan Pharmaceutical CoLtd and InnoTherapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InnoTherapy and Daihan Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Daihan Pharmaceutical CoLtd are associated (or correlated) with InnoTherapy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InnoTherapy has no effect on the direction of Daihan Pharmaceutical i.e., Daihan Pharmaceutical and InnoTherapy go up and down completely randomly.

Pair Corralation between Daihan Pharmaceutical and InnoTherapy

Assuming the 90 days trading horizon Daihan Pharmaceutical CoLtd is expected to generate 0.65 times more return on investment than InnoTherapy. However, Daihan Pharmaceutical CoLtd is 1.54 times less risky than InnoTherapy. It trades about 0.08 of its potential returns per unit of risk. InnoTherapy is currently generating about -0.1 per unit of risk. If you would invest  2,615,000  in Daihan Pharmaceutical CoLtd on September 3, 2024 and sell it today you would earn a total of  125,000  from holding Daihan Pharmaceutical CoLtd or generate 4.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Daihan Pharmaceutical CoLtd  vs.  InnoTherapy

Daihan Pharmaceutical

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Daihan Pharmaceutical CoLtd are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Daihan Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

InnoTherapy

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days InnoTherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Daihan Pharmaceutical and InnoTherapy

The main advantage of trading using opposite Daihan Pharmaceutical and InnoTherapy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Daihan Pharmaceutical position performs unexpectedly, InnoTherapy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InnoTherapy will offset losses from the drop in InnoTherapy's long position.

The idea behind Daihan Pharmaceutical CoLtd and InnoTherapy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.